AZN - AstraZeneca PLC
NEXT EARNINGS:
Apr 29, 2026
EPS Est: $1.23
|
Rev Est: $14.7B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
Market Cap:
640.61B
Volume:
1,708,091
Avg Volume:
655,766
52 Week Range:
122.26-212.71
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Beta:
0.19
Last Dividend:
$2.67
Exchange:
NYSE
Country:
GB
Employees:
94,300
IPO Date:
1993-05-12
EPS (TTM):
3.30
P/E Ratio:
28.87
Revenue (TTM):
58.74B
Total Assets:
114.07B
Total Debt:
29.70B
Cash & Equiv:
5.71B
Rev Growth (5Y):
17.3%
EPS Growth (5Y):
17.0%
FCF Growth (5Y):
70.2%
ROCE:
16.9%
Debt/Equity:
0.74
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-10 | $1.06 | $2.18 | -51.4% | $15.5B | $14.6B | +6.2% |
| 2025-11-06 | $1.19 | $1.14 | +4.4% | $15.2B | $15.4B | -1.5% |
| 2025-07-29 | $1.09 | $1.09 | 0.0% | $14.5B | $14.8B | -2.1% |
| 2025-04-29 | $1.24 | $1.10 | +12.7% | $13.6B | $14.1B | -3.3% |
| 2025-02-06 | $1.05 | $1.07 | -1.9% | $14.9B | $13.3B | +11.6% |
| 2024-11-12 | $1.04 | $1.03 | +1.0% | $13.6B | $13.1B | +3.6% |
| 2024-07-25 | $0.99 | $1.20 | -17.5% | $12.9B | $13.1B | -1.1% |
| 2024-04-25 | $1.03 | $1.22 | -15.6% | $12.7B | $11.8B | +7.5% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 58.74B | 54.07B | 45.81B | 44.35B | 37.42B | 26.62B | 24.38B | 22.09B | 22.46B | 23.00B | 24.71B | 26.55B |
| Net Income | 10.26B | 7.04B | 5.96B | 3.29B | 112.00M | 3.20B | 1.33B | 2.15B | 3.00B | 3.50B | 2.83B | 1.23B |
| EPS | 3.30 | 1.14 | 1.91 | 1.06 | 0.04 | 1.22 | 0.52 | 0.85 | 1.19 | 1.39 | 1.12 | 0.49 |
| Total Assets | 114.07B | 104.03B | 101.12B | 96.48B | 105.36B | 66.73B | 61.38B | 60.65B | 63.35B | 62.53B | 60.12B | 58.59B |
| Total Debt | 29.70B | 30.11B | 28.62B | 29.14B | 30.69B | 20.38B | 18.23B | 19.11B | 17.81B | 16.81B | 15.05B | 10.84B |
| Cash & Equivalents | 5.71B | 5.49B | 5.84B | 6.17B | 6.33B | 7.83B | 5.37B | 4.83B | 3.32B | 5.02B | 6.24B | 6.36B |
| Operating Cash Flow | 14.57B | 11.86B | 10.35B | 9.81B | 5.96B | 4.80B | 2.97B | 2.62B | 3.58B | 4.14B | 3.32B | 7.06B |
| Free Cash Flow | 11.77B | 7.28B | 6.57B | 7.24B | 3.76B | 2.19B | 509.00M | 1.25B | 1.96B | 1.83B | 536.00M | 4.31B |
| FCF per Share | 3.80 | 2.35 | 2.10 | 2.34 | 1.33 | 0.84 | 0.20 | 0.49 | 0.77 | 0.72 | 0.21 | 1.71 |
| Book Value | 48.67B | 40.79B | 39.14B | 37.04B | 39.27B | 15.62B | 13.13B | 12.47B | 14.96B | 14.85B | 18.49B | 19.63B |
| Cash & ST Investments | 5.74B | 5.53B | 5.86B | 6.24B | 6.40B | 7.99B | 6.22B | 5.68B | 4.55B | 5.90B | 6.85B | 7.16B |
| ROC Equity | 0.21 | 0.17 | 0.15 | 0.09 | 0.00 | 0.20 | 0.10 | 0.17 | 0.20 | 0.24 | 0.15 | 0.06 |